Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism.
De Larichaudy J, Zufferli A, Serra F, Isidori AM, Naro F, Dessalle K, Desgeorges M, Piraud M, Cheillan D, Vidal H, Lefai E, Némoz G.
Skelet Muscle. 2012 Jan 18;2(1):2.
Related citations
PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ.
Curr Top Microbiol Immunol. 2010;346:267-78. Review.
IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
Dehoux M, Gobier C, Lause P, Bertrand L, Ketelslegers JM, Thissen JP.
Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E145-50. Epub 2006 Aug 22.
TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.
Moylan JS, Smith JD, Chambers MA, McLoughlin TJ, Reid MB.
Am J Physiol Cell Physiol. 2008 Oct;295(4):C986-93. Epub 2008 Aug 13.
Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA, Nystrom GJ, Lang CH.
Endocrinology. 2003 May;144(5):1770-9.
siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle.
Austin RL, Rune A, Bouzakri K, Zierath JR, Krook A.
Diabetes. 2008 Aug;57(8):2066-73. Epub 2008 Apr 28.
Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death.
Xu J, Yeh CH, Chen S, He L, Sensi SL, Canzoniero LM, Choi DW, Hsu CY.
J Biol Chem. 1998 Jun 26;273(26):16521-6.
Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
Gonçalves DA, Lira EC, Baviera AM, Cao P, Zanon NM, Arany Z, Bedard N, Tanksale P, Wing SS, Lecker SH, Kettelhut IC, Navegantes LC.
Endocrinology. 2009 Dec;150(12):5395-404. Epub 2009 Oct 16.
IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL.
Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E591-601. Epub 2004 Apr 20.
TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine.
Dogra C, Changotra H, Wedhas N, Qin X, Wergedal JE, Kumar A.
FASEB J. 2007 Jun;21(8):1857-69. Epub 2007 Feb 21.
Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor.
Zhao J, Brault JJ, Schild A, Goldberg AL.
Autophagy. 2008 Apr;4(3):378-80. Epub 2008 Jan 23.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle.
Frost RA, Nystrom GJ, Jefferson LS, Lang CH.
Am J Physiol Endocrinol Metab. 2007 Feb;292(2):E501-12. Epub 2006 Sep 26.
Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
Osawa Y, Uchinami H, Bielawski J, Schwabe RF, Hannun YA, Brenner DA.
J Biol Chem. 2005 Jul 29;280(30):27879-87. Epub 2005 Jun 9.
Mitochondria mediate tumor necrosis factor-alpha/NF-kappaB signaling in skeletal muscle myotubes.
Li YP, Atkins CM, Sweatt JD, Reid MB.
Antioxid Redox Signal. 1999 Spring;1(1):97-104.
Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes.
Sishi BJ, Engelbrecht AM.
Cytokine. 2011 May;54(2):173-84.
FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.
Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL.
Cell Metab. 2007 Dec;6(6):472-83.
Effect of ceramide on mesenchymal stem cell differentiation toward adipocytes.
Xu F, Yang CC, Gomillion C, Burg KJ.
Appl Biochem Biotechnol. 2010 Jan;160(1):197-212. Epub 2009 Jan 23.
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ.
Am J Physiol Cell Physiol. 2009 Jun;296(6):C1258-70. Epub 2009 Apr 8.
Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's disease.
She P, Zhang Z, Marchionini D, Diaz WC, Jetton TJ, Kimball SR, Vary TC, Lang CH, Lynch CJ.
Am J Physiol Endocrinol Metab. 2011 Jul;301(1):E49-61. Epub 2011 Apr 19.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on